Monopar Therapeutics, Inc. (MNPR)
70.65
-1.93
(-2.66%)
USD |
NASDAQ |
Oct 23, 16:00
71.89
+1.24
(+1.76%)
After-Hours: 20:00
Monopar Therapeutics Market Cap : 474.22M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 474.22M |
| October 22, 2026 | 487.17M |
| October 21, 2026 | 485.63M |
| October 20, 2026 | 498.25M |
| October 19, 2026 | 479.72M |
| October 16, 2026 | 464.95M |
| October 15, 2026 | 481.94M |
| October 14, 2026 | 490.66M |
| October 13, 2026 | 483.82M |
| October 12, 2026 | 517.18M |
| October 09, 2026 | 530.00M |
| October 08, 2026 | 563.69M |
| October 07, 2026 | 562.35M |
| October 06, 2026 | 534.09M |
| October 05, 2026 | 525.50M |
| October 02, 2026 | 523.35M |
| October 01, 2026 | 523.35M |
| September 30, 2026 | 534.76M |
| September 29, 2026 | 536.98M |
| September 28, 2026 | 561.95M |
| September 25, 2026 | 572.11M |
| September 24, 2026 | 596.31M |
| September 23, 2026 | 599.94M |
| September 22, 2026 | 648.60M |
| September 21, 2026 | 642.49M |
| Date | Value |
|---|---|
| September 18, 2026 | 647.53M |
| September 17, 2026 | 689.34M |
| September 16, 2026 | 680.95M |
| September 15, 2026 | 700.28M |
| September 14, 2026 | 727.07M |
| September 11, 2026 | 740.09M |
| September 10, 2026 | 738.07M |
| September 09, 2026 | 754.32M |
| September 08, 2026 | 767.74M |
| September 04, 2026 | 789.09M |
| September 03, 2026 | 795.73M |
| September 02, 2026 | 780.49M |
| September 01, 2026 | 789.15M |
| August 31, 2026 | 751.30M |
| August 28, 2026 | 751.03M |
| August 27, 2026 | 764.79M |
| August 26, 2026 | 763.31M |
| August 25, 2026 | 743.85M |
| August 24, 2026 | 747.47M |
| August 21, 2026 | 723.04M |
| August 20, 2026 | 744.25M |
| August 19, 2026 | 831.24M |
| August 18, 2026 | 799.09M |
| August 17, 2026 | 781.90M |
| August 14, 2026 | 758.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 269.76M |
| Amgen, Inc. | 237.46B |
| Anika Therapeutics, Inc. | 286.66M |
| BioCryst Pharmaceuticals, Inc. | 1.953B |
| Imunon, Inc. | 5.762M |
Market Cap Related Metrics
| Price to Book Value | 3.624 |
| Price | 70.65 |
| Earnings Yield | -3.31% |